Description
NATtrol™ Norovirus GII Stock (NATNOVII-ST)* is formulated with purified, intact recombinant virus particles that have been chemically modified to render them noninfectious and refrigerator stable. Each vial contains 1.0 mL of Norovirus GII NATtrol™ that contains ~1Kb sequence of the Norovirus GII genome engineered into a surrogate RNA virus. NATNOVII-ST is supplied in a purified protein matrix that mimics the composition of a true clinical specimen.
Related Products
NATtrol Norovirus Group II Recombinant Stock 1 mL
2
NULL1,538.00
NATtrol Norovirus Group II (Recombinant) Stock (1 mL)
2-NATNOVII-ST-GEN
NATtrol Norovirus Group I Recombinant Stock
2
NULL1,403.00
NATtrol™ Norovirus GI Stock (NATNOVI-ST)* is formulated with purified, intact virus particles that have been chemically modified to render them non-infectious and refrigerator stable. Each vial...
02-NATNOVI-ST-GEN
NATtrol Norovirus Group II Recombinant Stool Matrix
2
NULL298.00
NATtrol™ GP (Gastrointestinal Pathogen) External Run Controls* are formulated with purified, intact organisms that have been chemically modified to render them non-infectious and refrigerator stable*...
02-NATNOVII-GP-GEN
NATtrol Norovirus Group I Recombinant Stock 1 mL
2
NULL1,538.00
NATtrol Norovirus Group I (Recombinant) Stock (1 mL)
2-NATNOVI-ST-GEN
NATtrol Norovirus Group II Recombinant Stool Matrix 0.5 mL
2
NULL494.00
NATtrol Norovirus Group II (Recombinant) (Stool Matrix) (0.5 mL)
2-NATNOVII-GP-GEN